HDFC Mutual Fund Increases Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has significantly bolstered its position in Global Health, the parent company of the renowned Medanta hospital chain, through a massive open market transaction. This strategic move signals continued institutional confidence in the healthcare sector's growth trajectory.

Strategic Accumulation by HDFC Mutual Fund

In a significant block deal executed on the BSE, HDFC Mutual Fund acquired an additional 10 lakh shares of Global Health. This latest acquisition was priced at an average of ₹1,300 per share, bringing the total transaction value to approximately ₹130 crore. This purchase represents a 0.37 per cent increase in the fund's stake in the company.

This move follows a pattern of aggressive accumulation by the fund house. Just last month, HDFC Mutual Fund had already purchased 10 lakh shares from the same source for over ₹122 crore. The repeated interest suggests that institutional investors view Global Health as a high-conviction play within the medical services segment.

Stake Transfer from Medanta Co-Founder

The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. As of the end of the March quarter, Sachdeva held a substantial 10.79 per cent stake in Global Health, consisting of 2.90 crore equity shares. While the co-founder has opted to liquidate a portion of his holdings, the transfer to a major institutional player like HDFC Mutual Fund ensures that the equity remains within the institutional ecosystem.

Despite the high-value transaction, the broader market reacted with slight volatility; shares of Global Health closed at ₹1,311.35 on the BSE, marking a marginal dip of 0.41 per cent.

Robust Financial Performance Drives Investor Interest

The institutional appetite for Global Health is likely underpinned by the company's stellar financial performance. For the fourth quarter ended March 31, 2026, Global Health reported a significant surge in profitability and top-line growth.

The company's Profit After Tax (PAT) climbed by 39.7 per cent to reach ₹141.7 crore, compared to ₹101.4 crore in the same quarter of the previous fiscal year. Furthermore, revenue from operations saw a healthy jump, rising to ₹1,159 crore from ₹931.3 crore in the year-ago period. These figures highlight the company's ability to scale operations and improve margins effectively, making it an attractive prospect for long-term institutional investors.

Key Takeaways

  • Aggressive Buying: HDFC Mutual Fund has acquired 10 lakh additional shares of Global Health at ₹1,300 per share, totaling a ₹130 crore investment.
  • Founder Exit: The shares were purchased from co-founder Sunil Sachdeva, who previously held a 10.79 per cent stake in the company.
  • Strong Fundamentals: The investment coincides with Global Health's strong Q4 FY26 results, featuring a 39.7% jump in PAT and robust revenue growth.